News & blog

Arcis Biotechnology Secures £2.5 Million Investment

Molecular innovation experts, Arcis Biotechnology today announces that it has raised £2.5 million in an oversubscribed fundraise, supported by existing shareholders and new investors. Now valued at circa £15million, the company will continue to commercialise its ground-breaking R&D-led portfolio of products, including bringing its novel malaria diagnostic test to market to help detect this globally significant disease quickly, in its very early stages, and crucially, at a low cost.

Read more